Diagens Biotech’s AI Imaging Platform iMedImage Makes Hong Kong IPO Debut
China-based Hangzhou Diagens Biotechnology Co., Ltd. has filed for an initial public offering (IPO) with...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity